ASSETS |
Investments in real estate, net |
5.72B |
Investments in unconsolidated partnerships |
29.37M |
LIABILITIES AND EQUITY/CAPITAL |
Mortgage notes payable, net |
492.07M |
Exchangeable senior notes, net |
0 |
Unsecured senior notes, net |
1.29B |
Unsecured line of credit |
463M |
BIOMED REALTY TRUST, INC. [Member] |
ASSETS |
Investments in real estate, net |
5.72B |
Investments in unconsolidated partnerships |
29.37M |
Cash and cash equivalents |
48.68M |
Restricted cash |
Accounts receivable, net |
19.14M |
Accrued straight-line rents, net |
177.42M |
Acquired above-market leases, net |
Deferred leasing costs, net |
226.96M |
Deferred loan costs, net |
Other assets |
237.89M |
Total assets |
6.46B |
LIABILITIES AND EQUITY/CAPITAL |
Mortgage notes payable, net |
492.07M |
Exchangeable senior notes, net |
0 |
Unsecured senior notes, net |
1.29B |
Unsecured line of credit |
463M |
Security deposits |
Dividends and distributions payable |
Accounts payable, accrued expenses and other liabilities |
Derivative instruments |
Acquired below-market leases, net |
Total liabilities |
3.41B |
Stockholders' equity:/Partners' capital: |
Preferred stock, $.01 par value, 15,000,000 shares authorized: 7.375% Series A cumulative redeemable preferred stock, $230,000,000 liquidation preference ($25.00 per share), 9,200,000 shares issued and outstanding at June 30, 2011 and December 31, 2010 |
Common stock, $.01 par value, 200,000,000 shares authorized, 131,259,602 and 131,046,509 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
2.04M |
Additional paid-in capital |
3.75B |
Accumulated other comprehensive loss |
-39.73M |
Dividends in excess of earnings |
-735.63M |
Total stockholders' equity |
2.98B |
Noncontrolling interests /Noncontrolling interests deficit |
65.29M |
Total equity/capital |
3.05B |
Total liabilities and equity/capital |
6.46B |
BIOMED REALTY, L.P. [Member] |
ASSETS |
Investments in real estate, net |
Investments in unconsolidated partnerships |
29.37M |
Cash and cash equivalents |
48.68M |
Restricted cash |
Accounts receivable, net |
19.14M |
Accrued straight-line rents, net |
177.42M |
Acquired above-market leases, net |
Deferred leasing costs, net |
226.96M |
Deferred loan costs, net |
Other assets |
237.89M |
Total assets |
6.46B |
LIABILITIES AND EQUITY/CAPITAL |
Mortgage notes payable, net |
Exchangeable senior notes, net |
Unsecured senior notes, net |
Unsecured line of credit |
Security deposits |
Dividends and distributions payable |
Accounts payable, accrued expenses and other liabilities |
Derivative instruments |
Acquired below-market leases, net |
Total liabilities |
3.41B |
Stockholders' equity:/Partners' capital: |
Preferred units, 7.375% Series A cumulative redeemable preferred units, $230,000,000 liquidation preference ($25.00 per unit), 9,200,000 units issued and outstanding at June 30, 2011 and December 31, 2010 |
Limited partners' capital, 2,979,979 and 3,001,250 units issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
42.48M |
General partner's capital, 131,239,482 and 131,046,509 units issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
3.02B |
Accumulated other comprehensive loss |
-35.81M |
Total partners' capital |
3.02B |
Noncontrolling interests /Noncontrolling interests deficit |
22.8M |
Total equity/capital |
3.05B |
Total liabilities and equity/capital |
6.46B |